Thor Medical Stock price

Equities

NANOV

NO0010597883

Biotechnology & Medical Research

Market Closed - Oslo Bors 09:20:00 2024-03-27 am EDT 5-day change 1st Jan Change
1.074 NOK +4.27% Intraday chart for Thor Medical +20.81% -16.74%
Dynamic Chart
1 day+4.27%
1 week+20.81%
Current month+5.50%
1 month-2.36%
3 months-22.17%
6 months-28.11%
Current year-16.74%
More quotes
1 week
0.87
Extreme 0.87
1.18
1 month
0.85
Extreme 0.85
1.18
Current year
0.85
Extreme 0.85
1.47
1 year
0.85
Extreme 0.85
2.30
3 years
0.85
Extreme 0.85
2.30
5 years
0.85
Extreme 0.85
2.30
10 years
0.85
Extreme 0.85
2.30
More quotes
Thor Medical ASA, formerly Nordic Nanovector ASA, is a Norway-based biopharmaceutical company. The Company is engaged in the development and commercialization of targeted therapeutics for hematological cancers. Its main product is Betalutin, a CD37-targeting radio-immunoconjugate designed to advance the treatment of non-Hodgkin lymphoma (NHL). Betalutin uses monoclonal antibodies to attack the cancer cells in two ways, first as an immunotherapy and secondly as a targeting agent for a radioactive payload and is a combination of radiation therapy and immunotherapy. The Company is also leveraging its expertise in radionuclides and CD37-targeting antibodies, along with partners, to build a pipeline of biopharmaceuticals for a range of haematological cancers.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
  1. Stock
  2. Equities
  3. Stock Thor Medical - Oslo Bors